Paul‐André Bryon

884 total citations
18 papers, 687 citations indexed

About

Paul‐André Bryon is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Paul‐André Bryon has authored 18 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 4 papers in Genetics. Recurrent topics in Paul‐André Bryon's work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Paul‐André Bryon is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Paul‐André Bryon collaborates with scholars based in France. Paul‐André Bryon's co-authors include Bertrand Coiffier, Pascale Felman, Françoise Berger, Martine Ffrench, Y Bastion, Evelyne Callet‐Bauchu, Catherine Thiéblemont, Gilles Salles, Lucille Baseggio and Jean‐Pierre Magaud and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Paul‐André Bryon

18 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul‐André Bryon France 14 509 338 265 150 91 18 687
PA Bryon France 9 531 1.0× 340 1.0× 356 1.3× 79 0.5× 80 0.9× 18 669
C. Jonas United States 4 509 1.0× 350 1.0× 266 1.0× 87 0.6× 111 1.2× 9 718
Flora N. Kontopidou Greece 17 427 0.8× 216 0.6× 255 1.0× 82 0.5× 112 1.2× 37 615
J Pierson United States 12 519 1.0× 340 1.0× 242 0.9× 108 0.7× 141 1.5× 13 651
Yiu‐Lam Kwan Australia 7 458 0.9× 438 1.3× 240 0.9× 82 0.5× 49 0.5× 15 661
Michaela Feuring Buske Germany 3 540 1.1× 345 1.0× 321 1.2× 101 0.7× 144 1.6× 5 732
TC Greiner United States 8 709 1.4× 454 1.3× 317 1.2× 111 0.7× 176 1.9× 10 824
Audrey Sylvia Baur Switzerland 12 417 0.8× 292 0.9× 222 0.8× 77 0.5× 107 1.2× 15 716
Elif Yakisan Germany 11 391 0.8× 254 0.8× 113 0.4× 176 1.2× 135 1.5× 12 747
Catherine Traullé France 12 354 0.7× 227 0.7× 184 0.7× 87 0.6× 76 0.8× 20 588

Countries citing papers authored by Paul‐André Bryon

Since Specialization
Citations

This map shows the geographic impact of Paul‐André Bryon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul‐André Bryon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul‐André Bryon more than expected).

Fields of papers citing papers by Paul‐André Bryon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul‐André Bryon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul‐André Bryon. The network helps show where Paul‐André Bryon may publish in the future.

Co-authorship network of co-authors of Paul‐André Bryon

This figure shows the co-authorship network connecting the top 25 collaborators of Paul‐André Bryon. A scholar is included among the top collaborators of Paul‐André Bryon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul‐André Bryon. Paul‐André Bryon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ghesquières, Hervé, Françoise Berger, Pascale Felman, et al.. (2006). Clinicopathologic Characteristics and Outcome of Diffuse Large B-Cell Lymphomas Presenting With an Associated Low-Grade Component at Diagnosis. Journal of Clinical Oncology. 24(33). 5234–5241. 48 indexed citations
2.
Baseggio, Lucile, Sophie Gazzo, Evelyne Callet‐Bauchu, et al.. (2005). An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement. Leukemia & lymphoma. 46(9). 1369–1374. 4 indexed citations
3.
Ffrench, Patrick, et al.. (2003). CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes. European Journal of Cell Biology. 82(5). 253–261. 5 indexed citations
4.
Berger, Françoise, Pascale Felman, Catherine Thiéblemont, et al.. (2000). Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood. 95(6). 1950–1956. 214 indexed citations
5.
Wołowiec, Dariusz, Yahia Mekki, Patrick Ffrench, et al.. (1996). Differential expression of cell proliferation regulatory proteins in B‐ and T‐lineage acute lymphoblastic leukaemias. British Journal of Haematology. 95(3). 518–523. 20 indexed citations
6.
Deviller, P, Catherine Souchier, Ruth Rimokh, et al.. (1995). CDK1 is a marker of proliferation in human lymphoid cells. International Journal of Cancer. 61(3). 381–388. 19 indexed citations
7.
Ffrench, Patrick, Denis Guyotat, Martine Ffrench, et al.. (1994). Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation. European Journal Of Haematology. 52(5). 296–301. 20 indexed citations
8.
Rimokh, Ruth, Françoise Berger, Martine Ffrench, et al.. (1991). Involvement of theBCL2Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle. Leukemia & lymphoma. 4(5-6). 355–362. 3 indexed citations
9.
Bastion, Y, Françoise Berger, Paul‐André Bryon, et al.. (1991). Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years. Annals of Oncology. 2 Suppl 2. 123–129. 91 indexed citations
10.
Tigaud, J, et al.. (1991). Ifosfamide continuous infusion plus etoposide in the treatment of elderly patients with aggressive lymphoma: A phase II study. Hematological Oncology. 9(4-5). 225–233. 17 indexed citations
11.
Bastion, Y, Françoise Berger, Paul‐André Bryon, et al.. (1991). Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years. Annals of Oncology. 2. 123–129. 63 indexed citations
12.
Bastion, Y, Bertrand Coiffier, Pascale Felman, et al.. (1990). Massive mediastinal extramedullary hematopoiesis in hereditary spherocytosis: A case report. American Journal of Hematology. 35(4). 263–265. 15 indexed citations
13.
Rimokh, Ruth, Karim Wahbi, Martine Ffrench, et al.. (1990). Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chromosomes and Cancer. 2(3). 223–226. 52 indexed citations
14.
15.
Coiffier, Bertrand, et al.. (1987). Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer. 60(12). 3029–3032. 30 indexed citations
16.
Cohen, J., Jean‐Pierre Revillard, Jean‐Pierre Magaud, et al.. (1987). B-Cell Maturation Stages of Burkitt's Lymphoma Cell Lines According to Epstein-Barr Virus Status and Type of Chromosome Translocation<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 78(2). 235–42. 27 indexed citations
17.
Bertrand, Suzanne, Roland Berger, Thierry Philip, et al.. (1981). Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein-Barr virus negative tumour and in a derived cell line. European Journal of Cancer (1965). 17(5). 577–581. 27 indexed citations
18.
Bouhours, Danièle, Jean‐François Bouhours, & Paul‐André Bryon. (1981). Association of glycoproteins and pepsinogen in the secretory granules of fundic epithelial cells isolated from guinea pig stomach. Biochimica et Biophysica Acta (BBA) - General Subjects. 672(3). 288–296. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by PA Bryon Breakdown of academic impact, for papers by C. Jonas Breakdown of academic impact, for papers by Flora N. Kontopidou Breakdown of academic impact, for papers by J Pierson Breakdown of academic impact, for papers by Yiu‐Lam Kwan Breakdown of academic impact, for papers by Michaela Feuring Buske Breakdown of academic impact, for papers by TC Greiner Breakdown of academic impact, for papers by Audrey Sylvia Baur Breakdown of academic impact, for papers by Elif Yakisan Breakdown of academic impact, for papers by Catherine Traullé
Rankless by CCL
2026